Natasha Belausov

Suggest Changes
Learn More
BACKGROUND Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) infections are emerging, but their clinical significance remains unclear. Our objective was to compare patients who(More)
  • 1